The economics of immune tolerance and treatment of hemophiliacs with inhibitors
Vox Sang
.
1996:70 Suppl 1:74-6.
Authors
C M Kessler
1
,
L M Aledort
Affiliation
1
Hematology and Oncology Division, George Washington University Medical Center, Washington, DC 20037, USA.
PMID:
8869476
No abstract available
MeSH terms
Factor VIII / therapeutic use
Health Care Costs*
Hemophilia A / drug therapy
Hemophilia A / economics*
Hemophilia A / immunology
Humans
Immune Tolerance*
Substances
Factor VIII